Seeking Alpha

Teva (TEVA -0.6%) and Lonza (LZAGY.PK -5.8%) mutually agree to terminate their biosimilars...

Teva (TEVA -0.6%) and Lonza (LZAGY.PK -5.8%) mutually agree to terminate their biosimilars collaboration following a strategic review. TEVA will continue to pursue its biologics strategy while Lonza will focus on its core competencies including contract manufacturing and cell line development. (PR)
From other sites
Comments (3)
  • doc47
    , contributor
    Comments (1314) | Send Message
     
    Yet another waste of time and money. I repeat the question: When is the last time Teva did anything right?
    25 Jul 2013, 11:04 AM Reply Like
  • dow43
    , contributor
    Comments (5) | Send Message
     
    when they bought Celerant and ratiopharm!
    25 Jul 2013, 09:42 PM Reply Like
  • doc47
    , contributor
    Comments (1314) | Send Message
     
    Really!? No wonder the stock has gone nowhere!
    26 Jul 2013, 10:07 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs